A top breast cancer researcher has continually failed to disclose potential conflicts of interest in his research after receiving millions of dollars from drug and healthcare companies, according to a report from Pro Publicaand The New York Times.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,